Why Surgery Partners (SGRY) stock is trading up today
Surgery Partners (SGRY) stock rose 46.4% after HealthSpan Partners agreed to acquire it for $5.7B. Shareholders will receive $23.50 per share, a 49% premium. The deal is expected to close in Q1 2027, pending approvals. SGRY shares are up 51.6% YTD, hitting a 52-week high.
How this was made

The 30-second read
Why it matters
The cash offer at $23.50 per share represents a 49% premium, prompting a 46.4% share surge and setting a new 52‑week high.
Market read
The deal is a material event for the healthcare sector, driving immediate price action and signaling continued consolidation.
What to watch
Potential integration costs and the $109 M termination fee may affect long‑term value beyond the premium.
Background
Surgery Partners provides outpatient surgical facilities; the acquisition by HealthSpan Partners (Bon Secours Mercy Health affiliate) creates a larger integrated health platform.
Ticker impact
Shares jumped 46.4% after HealthSpan Partners announced a $23.50 cash‑per‑share acquisition valued at $5.7 B.
upward pressure as the deal closes, with potential moderation after the initial jump.
The cash offer at a 49% premium is a material catalyst, and the trade is already reflected in the 46% intraday move.
Market effects
Consolidation in the outpatient surgery services sector may lift peers and increase M&A activity.
U.S. healthcare M&A sentiment improves, supporting related healthcare stocks.
Large‑cap healthcare deal highlights continued capital deployment in the sector worldwide.
Counterpoint
Deal risk (antitrust, financing) could cause a pull‑back if approvals stall, making the post‑jump price vulnerable.
Key entities
- CompanySurgery Partners
Target of the acquisition, ticker SGRY.
- CompanyHealthSpan Partners
Acquirer, affiliate of Bon Secours Mercy Health.
